[go: up one dir, main page]

AU2014905039A0 - Dislodgement and release of HSC using alpha 9 integrin antagonist and CXCR4 antagonist - Google Patents

Dislodgement and release of HSC using alpha 9 integrin antagonist and CXCR4 antagonist

Info

Publication number
AU2014905039A0
AU2014905039A0 AU2014905039A AU2014905039A AU2014905039A0 AU 2014905039 A0 AU2014905039 A0 AU 2014905039A0 AU 2014905039 A AU2014905039 A AU 2014905039A AU 2014905039 A AU2014905039 A AU 2014905039A AU 2014905039 A0 AU2014905039 A0 AU 2014905039A0
Authority
AU
Australia
Prior art keywords
antagonist
dislodgement
hsc
alpha
release
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2014905039A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Publication of AU2014905039A0 publication Critical patent/AU2014905039A0/en
Priority to CN201580075649.2A priority Critical patent/CN107206085B/en
Priority to BR112017012366A priority patent/BR112017012366A2/en
Priority to EP15867330.1A priority patent/EP3229817A4/en
Priority to SG11201704756YA priority patent/SG11201704756YA/en
Priority to KR1020177019249A priority patent/KR20170105514A/en
Priority to AU2015362089A priority patent/AU2015362089B2/en
Priority to JP2017531251A priority patent/JP6920990B2/en
Priority to CA2970114A priority patent/CA2970114A1/en
Priority to US15/535,144 priority patent/US20170340693A1/en
Priority to PCT/AU2015/050783 priority patent/WO2016090434A1/en
Priority to JP2021080506A priority patent/JP2021138709A/en
Abandoned legal-status Critical Current

Links

AU2014905039A 2014-12-12 2014-12-12 Dislodgement and release of HSC using alpha 9 integrin antagonist and CXCR4 antagonist Abandoned AU2014905039A0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
PCT/AU2015/050783 WO2016090434A1 (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
KR1020177019249A KR20170105514A (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
BR112017012366A BR112017012366A2 (en) 2014-12-12 2015-12-11 hsc displacement and release using alpha-9-integrin antagonist and cxcr4 antagonist.
EP15867330.1A EP3229817A4 (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
SG11201704756YA SG11201704756YA (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
CN201580075649.2A CN107206085B (en) 2014-12-12 2015-12-11 Using alpha9Migration and release of HSCs for integrin antagonists and CXCR4 antagonists
AU2015362089A AU2015362089B2 (en) 2014-12-12 2015-12-11 Dislodgement and release of HSC using alpha 9 integrin antagonist and CXCR4 antagonist
JP2017531251A JP6920990B2 (en) 2014-12-12 2015-12-11 Removal and release of HSCs with alpha 9 integrin antagonists and CXCR4 antagonists
CA2970114A CA2970114A1 (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
US15/535,144 US20170340693A1 (en) 2014-12-12 2015-12-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
JP2021080506A JP2021138709A (en) 2014-12-12 2021-05-11 Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonis

Publications (1)

Publication Number Publication Date
AU2014905039A0 true AU2014905039A0 (en) 2015-01-15

Family

ID=

Similar Documents

Publication Publication Date Title
EP3229817A4 (en) Dislodgement and release of hsc using alpha 9 integrin antagonist and cxcr4 antagonist
EP3209308A4 (en) Activated bifidobacteria and methods of use thereof
EP3209213A4 (en) Surgical devices and methods of use thereof
EP3092479A4 (en) Surgical devices and methods of use thereof
EP3268369A4 (en) Anti-alphavbeta1 integrin inhibitors and methods of use
EP3110820A4 (en) Tyk2 inhibitors and uses thereof
EP3200791A4 (en) PROCESSES AND INTERMEDIATES IN THE PREPARATION OF C5aR ANTAGONISTS
EP3094346A4 (en) Vista antagonist and methods of use
EP3105217A4 (en) Isoquinoline derivatives and use thereof
EP3227310A4 (en) Heterobifunctional inhibitors of e-selectins and cxcr4 chemokine receptors
SG11201605714VA (en) Block copolymer and adhesive composition
SG11201605762QA (en) Block copolymer composition and adhesive composition
EP3200806A4 (en) Nanofiber structures and methods of synthesis and use thereof
SG11201609355VA (en) Crumb of block copolymer and pressure-sensitive adhesive composition
EP3357934B8 (en) Polymer particles and use thereof
EP3509612A4 (en) Cxcr4 antagonists and methods of use
EP3152281A4 (en) Defoaming agent and associated methods of use
IL266345A (en) Dihydropyrimidine compound and preparation method and use thereof
EP3204424A4 (en) Combination therapy of inhibitors of c-c chemokine receptor type 9 (ccr9) and anti-alha4beta7 integrin blocking antibodies
EP3253408A4 (en) Anti-pre-bcr antagonists and methods
HUE050975T2 (en) Inhibitors of adapter associated kinase 1, compositions comprising them, and methods of their use
EP3375781A4 (en) Benzo ring derivative with b2 receptor agonist and m3 receptor antagonist activities and use thereof in medicine
IL261645A (en) Dioxo-hexahydroisoindolyl derivatives and their use as cyclophilin inhibitors
EP3101020A4 (en) Deuterated quinazolinone compound and pharmaceutical composition comprising same
EP3421596A4 (en) Alpha amylase variant and use thereof